BFG
GSK icon

Beacon Financial Group’s GSK GSK Stock Holding History

Beacon Financial Group’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-9,049
Closed -$531K – 177
2019
Q4 		$531K Buy
9,049
+2,687
+42% +$149K 0.07% 151
2019
Q3 		$324K Sell
6,362
-8
-0.1% -$412 0.06% 166
2019
Q2 		$319K Sell
6,370
-24
-0.4% -$1.2K 0.05% 173
2019
Q1 		$334 Sell
6,394
-4,108
-39% -$205K 0.05% 156
2018
Q4 		$501K Sell
10,502
-4,946
-32% -$244K 0.09% 130
2018
Q3 		$776K Sell
15,448
-1,198
-7% -$60.9K 0.13% 112
2018
Q2 		$839K Sell
16,646
-881
-5% -$44.4K 0.14% 110
2018
Q1 		$856K Buy
17,527
+390
+2% +$18.2K 0.15% 110
2017
Q4 		$760K Sell
17,137
-117,762
-87% -$5.44M 0.13% 115
2017
Q3 		$6.85M Sell
134,899
-479
-0.4% -$24.3K 1.24% 33
2017
Q2 		$7.32M Buy
135,378
+7,364
+6% +$393K 1.39% 31
2017
Q1 		$6.8M Buy
128,014
+3,624
+3% +$184K 1.3% 34
2016
Q4 		$5.99M Sell
124,390
-424
-0.3% -$20.9K 1.22% 35
2016
Q3 		$6.69M Buy
124,814
+4,230
+4% +$232K 1.41% 28
2016
Q2 		$6.4M Buy
120,584
+1,754
+1% +$92.4K 1.4% 28
2016
Q1 		$6.04M Buy
118,830
+1,324
+1% +$65.9K 1.31% 28
2015
Q4 		$6.03M Buy
117,506
+4,640
+4% +$237K 1.39% 27
2015
Q3 		$5.3M Sell
112,866
-1,250
-1% -$65.1K 1.3% 27
2015
Q2 		$6M Buy
114,116
+19,047
+20% +$1.07M 1.3% 25
2015
Q1 		$5.61M Buy
95,069
+41,831
+79% +$2.4M 1.24% 26
2014
Q4 		$2.85M Sell
53,238
-34,465
-39% -$1.93M 0.59% 61
2014
Q3 		$5.07M Buy
87,703
+1,757
+2% +$108K 1.1% 29
2014
Q2 		$5.78M Buy
85,946
+4,406
+5% +$298K 1.28% 23
2014
Q1 		$5.49M Sell
81,540
-752
-0.9% -$50.8K 1.13% 24
2013
Q4 		$5.46M Buy
82,292
+6,539
+9% +$424K 1.05% 21
2013
Q3 		$4.78M Buy
+75,753
New +$4.88M 1.03% 22

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Beacon Financial Group's GSK Position: Q1 2020 in Review

Beacon Financial Group sold out of GSK (GSK) in Q1 2020, closing a stake of 9,049 shares — an estimated $531K sold.

Beacon Financial Group first reported a position in GSK in Q3 2013 and held it in 26 quarters. The position peaked at $7.32M in Q2 2017. 817 funds tracked by Wall St. Rank hold GSK as of Q1 2020.

  • Beacon Financial Group reported no remaining GSK position as of Q1 2020 after selling out during the quarter.
  • Beacon Financial Group sold 9,049 GSK shares in Q1 2020, an estimated $531K.
  • Beacon Financial Group first reported a position in GSK in Q3 2013 and held it in 26 quarters.
  • Beacon Financial Group's GSK position peaked at $7.32M in Q2 2017.
  • 817 funds tracked by Wall St. Rank held GSK as of Q1 2020.

Based on Beacon Financial Group's 13F filing for Q1 2020, filed 29 Jun 2020.